Call MEDISCA now at 1-800-932-10391300 786 392

Functional and Personalised
Hormone Restoration Therapy:



Compounding hormone therapies and formulations present particular issues and challenges to the compounding pharmacist. The practice-based activity will provide compounding pharmacists with the opportunity to enhance their competency as it relates to the many therapeutic options used in hormone therapies.

Having been presented with a prescription indicating a need for a compounded medication, the participating pharmacist will use uniquely designed patient assessment tools, select appropriate delivery systems for the specific hormones and nutritional supplements prescribed, and then monitor patient progress. During this process the participant will have learned the physiologic features of the hormone systems in the body, how to conduct a patient needs analysis, and then work with physicians to provide pharmacist expertise with respect to the therapeutic, nutritional supplementation, and lifestyle and behavior modification options available to the physician.

Finally, participants will apply monitoring tools and strategies to maintain patient compliance with prescribed therapeutic initiatives. Case work will be documented and clinical findings recorded in a formal manner for purposes of confidential communication, record keeping and statistical analysis.


Physicians, pharmacists and nurse practitioners engaged in prescription hormone practice.


A two part activity; self-study with learning assessment and live event with case studies and competency assessment.


  1. Describe the hormone cascade.
  2. Describe the relative distribution of hormones in the body.
  3. Learn the physiological basis of hormone therapy.
  4. Learn the general hormone system functions; gonadal, adrenal and thyroid.
  5. Explain the female and male reproductive hormone system lifecycles.
  6. Review signs of female and male hormone imbalances.
  7. Describe principles of hormone functioning, relationships, and imbalance.
  8. Review test types, their advantages and disadvantages, used in hormone therapy.
  9. Review hormone therapy-related evidence-based medicine abstracts and citations.


  1. Evaluate and apply a unique set of rules applicable to customised hormone restoration therapy.
  2. Analyse physiological and biochemical features of endocrine system dysfunctions.
  3. Describe the hormone cascade, its neurobiological communication network, effects of exogenous and endogenous factors on the cascade, and impact on endocrine and neighbouring digestive and immune systems.
  4. Investigate and evaluate therapeutic alternatives for specific classifications related to hormone therapy and imbalance; specifically construct formulations, which may be prescribed or used by a healthcare provider in the treatment of perimenopause, menopause, andropause, thyroid dysfunction, adrenal dysfunction, metabolic syndrome, and sexual dysfunction.
  5. Interpret, integrate, and evaluate comprehensive patient assessment chart data; including prior medical history, familial history, differential diagnoses, lifestyle behaviours, signs and symptoms, and laboratory test results.
  6. Describe and design hormone-related medication options, adjunct pharmacotherapeutics, and nutraceutical treatments that are optimal and efficacious for the individual patient.
  7. Recognize and evaluate the various routes of delivery, delivery systems, dosage, forms and dispensing mechanisms used in hormone therapy, adjunct therapy, nutraceutical supplementation, and specific aspects of lifestyle management; and monitor patient responses through quantitative and qualitative systematic testing.



Dr. Tara Scott is a certified menopause practitioner with the North American Menopause Society, a fellow of the American College of Obstetrics and Gynecology, advanced fellow of the American Academy of Anti-Aging Medicine, and board certified in Integrative Medicine. Dr. Scott is also the Chief Medical Officer of Revilatize Medical Group and Medical Director of Summa Health in Akron, Ohio.


Dr. Ken Speidel is known for his experience in pharmacy practice and education, including his international recognition as a pharmacotherapeutic specialist in endocrinology and pain management, as well as his expertise in sterile and non-sterile compounding processes. Dr. Speidel is a retired Professor of Pharmacy from the University of Findlay (United States) and has assisted in the development and facilitation of various ACPE-accredited educational programs. Dr. Speidel was an advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB) and remains a surveyor and accreditation expert for PCAB/ACHC.

Other Facilitators may also be involved in the presentation of the Training Activity.


APC Accredited CPD

This activity has been accredited for 23 hours of Group 1 CPD (or 23 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 23 hours of Group 2 CPD (or 46 CPD credits) upon successful completion of relevant assessment activities.


Activity material is Copyright© 2008-2019 LP3 Network Inc.


Activity participants are required to achieve a 75% passing grade associated with a self-study learning assessment prior to attending the live event. Full attendance and the completion of a program evaluation and practical skill set competency evaluation are a compulsory requirement to achieve credit for the live event.


This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.


This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.


Special rates for hotel accommodations have been arranged for activity participants. Payment for hotel accommodations is at the expense of the activity participant.


As a matter of activity programming, meals and refreshments during live activities have been provided by MEDISCA Australia.


In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation.In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date.This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.


This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.


We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.

Copyright® 1989-2021 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified